Literature DB >> 29394500

Mutations in MICAL-1cause autosomal-dominant lateral temporal epilepsy.

Emanuela Dazzo1, Kati Rehberg2, Roberto Michelucci3, Daniela Passarelli4, Clementina Boniver5, Valeria Vianello Dri6, Pasquale Striano7, Salvatore Striano8, R Jeroen Pasterkamp2, Carlo Nobile1,9.   

Abstract

OBJECTIVE: Autosomal-dominant lateral temporal epilepsy (ADLTE) is a genetic focal epilepsy characterized by auditory symptoms. Two genes, LGI1 and RELN, encoding secreted proteins, are implicated in the etiology of ADLTE, but half of the affected families remain genetically unsolved, and the underlying molecular mechanisms are yet to be clarified. We aimed to identify additional genes causing ADLTE to better understand the genetic basis and molecular pathway underlying this epileptic disorder.
METHODS: A cohort of Italian ADLTE families was examined by whole exome sequencing combined with genome-wide single-nucleotide polymorphism-array linkage analysis.
RESULTS: We identified two ADLTE-causing variants in the MICAL-1 gene: a p.Gly150Ser substitution occurring in the enzymatically active monooxygenase (MO) domain and a p.Ala1065fs frameshift indel in the C-terminal domain, which inhibits the oxidoreductase activity of the MO domain. Each variant segregated with ADLTE in a single family. Examination of candidate variants in additional genes excluded their implication in ADLTE. In cell-based assays, both variants significantly increased MICAL-1 oxidoreductase activity and induced cell contraction in COS7 cells, which likely resulted from deregulation of F-actin dynamics.
INTERPRETATION: MICAL-1 oxidoreductase activity induces disassembly of actin filaments, thereby regulating the organization of the actin cytoskeleton in developing and adult neurons and in other cell types. This suggests that dysregulation of the actin cytoskeleton dynamics is a likely mechanism by which MICAL-1 pathogenic variants lead to ADLTE. Ann Neurol 2018;83:483-493.
© 2018 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29394500     DOI: 10.1002/ana.25167

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

Review 1.  MICAL1 Monooxygenase in Autosomal Dominant Lateral Temporal Epilepsy: Role in Cytoskeletal Regulation and Relation to Cancer.

Authors:  Sipan Haikazian; Michael F Olson
Journal:  Genes (Basel)       Date:  2022-04-19       Impact factor: 4.141

Review 2.  Imaging Genetics in Epilepsy: Current Knowledge and New Perspectives.

Authors:  Ge Wang; Wenyue Wu; Yuchen Xu; Zhuanyi Yang; Bo Xiao; Lili Long
Journal:  Front Mol Neurosci       Date:  2022-05-30       Impact factor: 6.261

3.  Human MICAL1: Activation by the small GTPase Rab8 and small-angle X-ray scattering studies on the oligomerization state of MICAL1 and its complex with Rab8.

Authors:  Alessandro Esposito; Valeria Ventura; Maxim V Petoukhov; Amrita Rai; Dmitri I Svergun; Maria A Vanoni
Journal:  Protein Sci       Date:  2018-10-31       Impact factor: 6.725

Review 4.  Epilepsy With Auditory Features: From Etiology to Treatment.

Authors:  Alessandro Furia; Laura Licchetta; Lorenzo Muccioli; Lorenzo Ferri; Barbara Mostacci; Stefania Mazzoni; Veronica Menghi; Raffaella Minardi; Paolo Tinuper; Francesca Bisulli
Journal:  Front Neurol       Date:  2022-01-27       Impact factor: 4.003

5.  Potential Cross Talk between Autism Risk Genes and Neurovascular Molecules: A Pilot Study on Impact of Blood Brain Barrier Integrity.

Authors:  Rekha Jagadapillai; Xiaolu Qiu; Kshama Ojha; Zhu Li; Ayman El-Baz; Shipu Zou; Evelyne Gozal; Gregory N Barnes
Journal:  Cells       Date:  2022-07-15       Impact factor: 7.666

6.  Neuropilin-2 Signaling Modulates Mossy Fiber Sprouting by Regulating Axon Collateral Formation Through CRMP2 in a Rat Model of Epilepsy.

Authors:  Yuxiang Li; Fangchao Tong; Yiying Zhang; Yiying Cai; Jing Ding; Qiang Wang; Xin Wang
Journal:  Mol Neurobiol       Date:  2022-08-31       Impact factor: 5.682

7.  MICAL1 constrains cardiac stress responses and protects against disease by oxidizing CaMKII.

Authors:  Klitos Konstantinidis; Vassilios J Bezzerides; Lo Lai; Holly M Isbell; An-Chi Wei; Yuejin Wu; Meera C Viswanathan; Ian D Blum; Jonathan M Granger; Danielle Heims-Waldron; Donghui Zhang; Elizabeth D Luczak; Kevin R Murphy; Fujian Lu; Daniel H Gratz; Bruno Manta; Qiang Wang; Qinchuan Wang; Alex L Kolodkin; Vadim N Gladyshev; Thomas J Hund; William T Pu; Mark N Wu; Anthony Cammarato; Mario A Bianchet; Madeline A Shea; Rodney L Levine; Mark E Anderson
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

Review 8.  Molecular typing of familial temporal lobe epilepsy.

Authors:  Chao Liu; Xiao-Zhi Qiao; Zi-Han Wei; Mi Cao; Zhen-Yu Wu; Yan-Chun Deng
Journal:  World J Psychiatry       Date:  2022-01-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.